Roivant Sciences Ltd [NASDAQ: ROIV] stock went on an upward path that rose over 0.27% on Tuesday, amounting to a one-week price decrease of less than -2.29%.
Over the last 12 months, ROIV stock rose by 2.78%. The one-year Roivant Sciences Ltd stock forecast points to a potential upside of 33.67. The average equity rating for ROIV stock is currently 1.20, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $7.55 billion, with 695.94 million shares outstanding and 418.04 million shares in the current float. Compared to the average trading volume of 6.60M shares, ROIV stock reached a trading volume of 6170636 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Roivant Sciences Ltd [ROIV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ROIV shares is $16.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ROIV stock is a recommendation set at 1.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for Roivant Sciences Ltd shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 15, 2024. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on January 05, 2024, representing the official price target for Roivant Sciences Ltd stock. Previously, the target price had yet another raise to $14, while Deutsche Bank analysts kept a Buy rating on ROIV stock.
The Average True Range (ATR) for Roivant Sciences Ltd is set at 0.34, with the Price to Sales ratio for ROIV stock in the period of the last 12 months amounting to 99.13. The Price to Book ratio for the last quarter was 1.65, with the Price to Cash per share for the same quarter was set at 7.19.
ROIV Stock Performance Analysis:
Roivant Sciences Ltd [ROIV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.29. With this latest performance, ROIV shares gained by 2.97% in over the last four-week period, additionally sinking by -6.48% over the last 6 months – not to mention a rise of 2.78% in the past year of trading.
#####
Insight into Roivant Sciences Ltd Fundamentals:
Roivant Sciences Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 33.47 and a Current Ratio set at 33.47.
Roivant Sciences Ltd [ROIV] Institutonal Ownership Details
The top three institutional holders of ROIV stocks are: SB INVESTMENT ADVISERS (UK) LTD with ownership of 71.36 million shares, which is approximately 9.6983%. VIKING GLOBAL INVESTORS LP, holding 69.16 million shares of the stock with an approximate value of $$730.98 million in ROIV stocks shares; and VIKING GLOBAL INVESTORS LP, currently with $$705.23 million in ROIV stock with ownership which is approximately 9.0674%.
